Michael M. Cohen, the president and CEO of a Paramus biotech firm, pleaded guilty today to misleading the U.S. Securities and Exchange Commission during an appearance in U.S. District Court in Newark. NEWARK - The president and CEO of a Paramus biotech firm that specializes in stem cell research admitted today that he misled federal securities regulators about stock transfers to companies he secretly controlled.
http://ift.tt/1zRKMvc
http://ift.tt/1zRKMvc
No comments:
Post a Comment